Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: A pooled analysis of three randomized clinical trials

European Heart Journal

Volumn 26, Issue 2, 2005, Pages 128-136

  Labinaz, Marino ^a   Mathias, Jasmine ^b   Pieper, Karen ^b   Granger, Christopher B ^b   Lincoff, A Michael ^c   Moliterno, David J ^c   Van De Werf, Frans ^d   Simes, John ^e   White, Harvey D ^f   Simoons, Maarten L ^g   Califf, Robert M ^b   Topol, Eric J ^c   Armstrong, Paul W ^h   Harrington, Robert A ^b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITY OF SYDNEY   (Australia)

^f GREEN LANE HOSPITAL   (New Zealand)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acute coronary syndrome; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRUDIN; LAMIFIBAN; NITRATE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; SYSTEMATIC REVIEW;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; RETREATMENT;

EID: 20044386659     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi061     Document Type: Article

References (24)

1. Cannon CP, Weintraub WS, Demopoulos LA et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887.
2. Lagerqvist B, Husted S, Kontny F et al. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. J Am Coll Cardiol 2002;40:1902-1914.
3. FRagmin and Fast Revascularisation during Instability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999;354:708-715.
4. Labinaz M, Kilaru R, Pieper K et al. for the PURSUIT Investigators. Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation 2002;105:322-327.
5. Kleiman NS, Anderson HV, Rogers WJ et al. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry). Am J Cardiol 1996;77:227-231.
6. Waters DD, Walling A, Roy D et al. Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris. Am J Cardiol 1986;58:465-469.
7. Wiseman A, Waters DD, Walling A et al. Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery. J Am Coll Cardiol 1988;12:873-880.
8. Labinaz M, Sketch MH Jr, Stebbins AL et al. for the GUSTO-I Investigators. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. Am J Cardiol 1996;78:1338-1344.
9. GUSTO-IIb Investigators. The Global Use of Strategies To Open Occluded Coronary Arteries: A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996;335:775-782.
10. The Platelet IIb/IIIa Antagonist-for the Reduction of Acute coronary syndrome events in a Global Organization Network (PARAGON)-B Investigators. Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes. Circulation 2002;105:316-321.
11. The PURSUIT Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998;339:436-443.
12. Boersma E, Pieper KS, Steyerberg EW et al. for the PURSUIT Investigators. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. Circulation 2000;101:2557-2567.
13. Marschner IC, Colquhoun C, Simes RJ et al. on behalf of the LIPID Study Investigators. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. J Am Coll Cardiol 2001;38:56-63.
14. Rodriguez A, Bernardi V, Navia J et al. for the ERACI II Investigators. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30 day and one-year follow-up results. J Am Coll Cardiol 2001;37:51-58.
15. Serruys PW, Unger F, Sousa JE et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-1124.
16. The SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 2002;360:965-970.
17. The Multicenter Postinfarction Research Group. Risk stratifaction and survival after myocardial infarction. N Engl J Med 1983;309:331-336.
18. Schulman SP, Achuff SC, Griffith LS et al. Prognostic cardiac catheterization variables in survivors of acute myocardial infarction: a five-year prospective study. J Am Coll Cardiol 1988;11:1164-1172.
19. Taylor GJ, Humphries JO, Mellits ED et al. Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation 1980;62:960-970.
20. Topol EJ, Holmes DR, Rogers WJ. Coronary angiography after thrombolytic therapy for acute myocardial infarction. Ann Intern Med 1991;114:877-885.
21. Williams DO, Amsterdam EA, Miller RR et al. Functional significance of coronary collateral vessels in patients with acute myocardial infarction: relation to pump performance, cardiogenic shock and survival. Am J Cardiol 1976;37:345-351.
22. Garcia-Dorado D, Theroux P, Tornos P et al. Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes. Circulation 1995;92:1743-1748.
23. Harjai KJ, Stone GW, Boura J et al. Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 2003;91:655-660.
24. Stenestrand U, Wallentin L, for the Swedish Register of Cardiac Intensive Care. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001;285:430-436.